Results 1 to 10 of about 50,700 (248)

Polycystic liver disease: a clinical review

Annals of Hepatology, 2012
Polycystic liver disease rarely occurs in isolation as part of autosomal dominant polycystic liver disease, but more commonly, it exists as an extra-renal manifestation of autosomal dominant polycystic kidney disease. The pathogenesis of polycystic liver
Natasha Chandok, M.D., MPH, FRCPC
doaj   +5 more sources

Simultaneous Echinococcal superinfection in a patient with polycystic liver disease [PDF]

Clinical Case Reports, 2023
Key Clinical Message Concurrent polycystic liver disease and echinococcus infection can hinder diagnosis. Surgery may be needed for accurate diagnosis and treatment. Multidisciplinary collaboration is crucial.
Ottavia Cicerone, Raffaella Lissandrin, Enrico Brunetti, Marcello Maestri   +3 more
doaj   +2 more sources

Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment [PDF]

Hepatic Medicine: Evidence and Research, 2022
Luiz Fernando Norcia,1 Erika Mayumi Watanabe,2 Pedro Tadao Hamamoto Filho,3 Claudia Nishida Hasimoto,1 Leonardo Pelafsky,1 Walmar Kerche de Oliveira,1 Ligia Yukie Sassaki4 1Department of Surgery, São Paulo State University (Unesp), Medical School ...
Norcia LF, Watanabe EM, Hamamoto Filho PT, Hasimoto CN, Pelafsky L, de Oliveira WK, Sassaki LY   +6 more
doaj   +2 more sources

Polycystic liver disease with lethal abdominal wall rupture: a case report [PDF]

Journal of Medical Case Reports, 2021
Background Polycystic liver disease is a clinical feature of autosomal dominant polycystic kidney disease, and it can sometimes cause health damage more serious than polycystic kidney.
Daichi Akuzawa, Yoichiro Uchida, Takuya Ishimura, Hiroko Kakita, Tomomi Endo, Naomi Matsuzaki, Hiroaki Terajima, Tatsuo Tsukamoto   +7 more
doaj   +2 more sources

Polycystic liver disease presenting with an exudative pleural effusion: a case report [PDF]

Journal of Medical Case Reports, 2012
Introduction Polycystic liver disease is asymptomatic in 95% of patients. In the remaining 5% it causes symptoms due to the local mass effect of the polycystic liver. We describe the case of a patient who presented with symptoms of a pleural effusion and
Woolnough Kerry, Palejwala Altav, Bramall Simon   +2 more
doaj   +4 more sources

Polycystic liver disease: An uncommon genetic condition [PDF]

Clinical Case Reports
Key Clinical Message Timely recognition, accurate diagnosis, and proper management are vital for preventing complications and improving outcomes in polycystic liver disease. Abstract Polycystic liver disease is an uncommon genetic condition characterized
Faten Limaiem, Mohamed Hajri
doaj   +2 more sources

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease [PDF]

BMC Nephrology, 2012
Background A large proportion of patients with autosomal dominant polycystic kidney disease (ADPKD) suffers from polycystic liver disease. Symptoms arise when liver volume increases.
Gevers Tom JG, Chrispijn Melissa, Wetzels Jack FM, Drenth Joost PH   +3 more
doaj   +4 more sources

Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis [PDF]

JHEP Reports, 2022
Background & Aims: Polycystic liver disease (PLD) manifests as numerous fluid-filled cysts scattered throughout the liver parenchyma. PLD most commonly develops in females, either as an extra-renal manifestation of autosomal-dominant polycystic ...
Dana Sierks, Ria Schönauer, Anja Friedrich, Elena Hantmann, Jonathan de Fallois, Nikolas Linder, Janett Fischer, Adam Herber, Carsten Bergmann, Thomas Berg, Jan Halbritter   +10 more
doaj   +2 more sources

Treatment of polycystic liver disease: a hypothesis, patient characteristics, short and long-term results

Annals of Hepatology, 2013
Background. Non-total liver resecting invasive treatment of polycystic liver disease has different recurrence rates. The aim of this study is to illustrate why the recurrence rates are different.
Zheng Long-Xian, Liu Ai-Wu, Qin Hua-Dong, Cui Jun, Jiang Hui-Jie, Jia Hong-Bo   +5 more
doaj   +2 more sources

Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease [PDF]

Orphanet Journal of Rare Diseases
Polycystic liver disease (PLD) is a rare condition observed in three genetic diseases, including autosomal dominant polycystic liver disease (ADPLD), autosomal dominant polycystic kidney disease (ADPKD), and autosomal recessive polycystic kidney disease (
Amir Ali Mahboobipour, Moein Ala, Javad Safdari Lord, Arash Yaghoobi   +3 more
doaj   +2 more sources